AstaraZeneca’Corona 19′ vaccine, which the Indian government decided to introduce. /Photo = Reuters
Reuters reported on the 1st that the Indian pharmaceutical authorities approved the emergency use of a novel coronavirus infection (Corona 19) vaccine developed by Oxford University and AstraZeneca in the UK.
Reportedly, this is the first time that the use of the Corona 19 vaccine has been approved in India. Prior to India, countries that approved the use of the AstraZeneca vaccine were the UK, Argentina, and El Salvador.
In India, the local pharmaceutical company Serum Institute (SII), the world’s largest vaccine company, has been conducting clinical trials of AstraZeneca vaccine.
SII has already finished producing 50 million doses in preparation for approval, and it is known that it plans to increase its production to 100 million doses per month by March.
The average immunity effect of AstraZeneca vaccine is 70.4%, which is lower than that of Pfizer (95%) or Modena (94.5%), but it has the advantage that it is cheap and can be stored in a general refrigerator (2-8℃).
India is expected to begin vaccinating soon after the approval. The number of priority vaccination targets set by the Indian government is about 300 million people, including medical staff, police, soldiers, and people in their 50s or older.
Meanwhile, the cumulative number of corona19 confirmed cases in India was 10,2867,091 on the day. The number of new confirmed cases a day, which reached 100,000 in September, has recently decreased to around 20,000.
Bobae Lee, guest reporter at Hankyung.com [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution